InterChem
Generated 5/9/2026
Executive Summary
InterChem is a US-based pharmaceutical services company specializing in the sourcing, logistics, and transportation of Active Pharmaceutical Ingredients (APIs) and antibiotics. Founded in 2005 and headquartered in San Diego, the company acts as a trusted intermediary, managing supply chain risk and coordinating custom manufacturing for pharmaceutical clients. Leveraging decades of industry relationships, InterChem ensures FDA-compliant and reliable sourcing, positioning itself as a critical partner in the pharmaceutical supply chain. Despite being private and lacking disclosed funding or valuation, the company's consistent focus on API logistics and its established network suggest a stable, though not high-growth, business model. The company's profile remains low in public visibility, with no recent news or regulatory milestones identified.
Upcoming Catalysts (preview)
- Q4 2026Expansion of API sourcing capabilities through new supplier agreements65% success
- TBDPotential contract win with a major pharmaceutical company for custom manufacturing coordination50% success
- Q2 2027Adoption of digital supply chain tracking technology to enhance transparency40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)